Effects of interferon therapy on development of hepatocellular carcinoma in patients with hepatitis C-related cirrhosis: A meta-analysis of randomized controlled trials-Reference-Cited by-同舟云学术

Effects of interferon therapy on development of hepatocellular carcinoma in patients with hepatitis C-related cirrhosis: A meta-analysis of randomized controlled trials

Published:2012-03-13 Issue:8 Volume:42 Page:782-789
ISSN:1386-6346
Container-title:Hepatology Research
language:en
Short-container-title:

Author:

Qu Li-Shuai,Chen Hong,Kuai Xiao-Ling,Xu Zheng-Fu,Jin Fei,Zhou Guo-Xiong

Publisher

Wiley

Subject

Infectious Diseases,Hepatology

Reference32 articles.

1. Hepatocellular carcinoma;Llovet;Lancet,2003

2. Diagnosis and treatment of hepatocellular carcinoma;El-Serag;Gastroenterology,2008

3. The epidemic behavior of the hepatitis C virus;Pybus;Science,2001

4. Risk factors for hepatocellular carcinoma among patients with chronic liver disease;Tsukuma;N Engl J Med,1993

5. Hepatitis C: somber views of natural history and optimistic views of interferon treatment?;Poynard;Hepatology,1998

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Chapter XX Antiviral Treatment and Cancer Control;Viruses and Human Cancer;2020-11-18

2. Pegylated interferon-α inhibits the proliferation of hepatocellular carcinoma cells by downregulating miR-155;Annals of Hepatology;2019-05

3. Serum metabolome profiles characterized by patients with hepatocellular carcinoma associated with hepatitis B and C;World Journal of Gastroenterology;2016

4. A Comprehensive Long-Term Prognosis of Chronic Hepatitis C Patients With Antiviral Therapy; A Meta-Analysis of Studies From 2008 to 2014;Hepatitis Monthly;2015-05-23

5. Dynamics of serum metabolites in patients with chronic hepatitis C receiving pegylated interferon plus ribavirin: A metabolomics analysis;Metabolism;2013-11